Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in Iran

BACKGROUND: Lisdexamfetamine (LDX) and Methylphenidate (MPH) are stimulant agents that have been shown to provide significant benefits in the management of attention-deficit/hyperactivity disorder (ADHD) in patients. AIM: This study aimed to assess the cost-effectiveness and the budget impact of LDX...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajik, Amirmohammad, Nikfar, Shekoufeh, Elyasi, Sepideh, Rajabi, Omid, Varmaghani, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566195/
https://www.ncbi.nlm.nih.gov/pubmed/37817221
http://dx.doi.org/10.1186/s13034-023-00664-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566195/
https://www.ncbi.nlm.nih.gov/pubmed/37817221
http://dx.doi.org/10.1186/s13034-023-00664-1

Ejemplares similares